Literature DB >> 21603479

New Onset LSD Flashback Syndrome Triggered by the Initiation of SSRIs.

Sarah Goldman, David Galarneau, Richard Friedman.   

Abstract

During the 1960s, lysergic acid diethylamide (LSD) emerged as a widely popular drug, used by a substantial portion of the adolescent and young adult population. Since Major Depressive Disorder is a common disorder, clinicians will increasingly encounter patients who used LSD in the far distant past and now require treatment with antidepressant agents. We describe such a case in the following report of a patient who experienced a troubling array of unusual side effects, which we postulate to be a new onset LSD flashback syndrome triggered by selective serotonin reuptake inhibitors (SSRIs).

Entities:  

Keywords:  LSD fashback; SSRIs; selective serotonin reuptake inhibitors

Year:  2007        PMID: 21603479      PMCID: PMC3096346     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  9 in total

1.  Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans.

Authors:  K R Bonson; J W Buckholtz; D L Murphy
Journal:  Neuropsychopharmacology       Date:  1996-06       Impact factor: 7.853

Review 2.  The psychopharmacology of hallucinogens.

Authors:  H D Abraham; A M Aldridge; P Gogia
Journal:  Neuropsychopharmacology       Date:  1996-04       Impact factor: 7.853

3.  Dissociations between the effects of hallucinogens on behavior and raphe unit activity in behaving cats.

Authors:  M E Trulson
Journal:  Pharmacol Biochem Behav       Date:  1986-02       Impact factor: 3.533

Review 4.  Adverse consequences of lysergic acid diethylamide.

Authors:  H D Abraham; A M Aldridge
Journal:  Addiction       Date:  1993-10       Impact factor: 6.526

5.  LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.

Authors:  H Markel; A Lee; R D Holmes; E F Domino
Journal:  J Pediatr       Date:  1994-11       Impact factor: 4.406

Review 6.  A molecular and cellular theory of depression.

Authors:  R S Duman; G R Heninger; E J Nestler
Journal:  Arch Gen Psychiatry       Date:  1997-07

Review 7.  Serotonin and hallucinogens.

Authors:  G K Aghajanian; G J Marek
Journal:  Neuropsychopharmacology       Date:  1999-08       Impact factor: 7.853

8.  A single dose of lysergic acid diethylamide influences gene expression patterns within the mammalian brain.

Authors:  Charles D Nichols; Elaine Sanders-Bush
Journal:  Neuropsychopharmacology       Date:  2002-05       Impact factor: 7.853

Review 9.  Hallucinogen persisting perception disorder: what do we know after 50 years?

Authors:  John H Halpern; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2003-03-01       Impact factor: 4.492

  9 in total
  3 in total

Review 1.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

2.  Distressing Visual Hallucinations after Treatment with Trazodone.

Authors:  Gustavo Santos; Ana Maria Moreira
Journal:  Case Rep Psychiatry       Date:  2017-06-18

3.  Visual snow syndrome after start of citalopram-novel insights into underlying pathophysiology.

Authors:  Ozan E Eren; Florian Schöberl; Christoph J Schankin; Andreas Straube
Journal:  Eur J Clin Pharmacol       Date:  2020-09-16       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.